A Cohort Study in Liver Transplant Patients Converted From a Tacrolimus Twice a Day (Prograf) to Tacrolimus Once a Day (Advagraf). French, Multisite, Observational Study
Phase of Trial: Phase IV
Latest Information Update: 29 Sep 2017
Price : $35 *
At a glance
- Drugs Tacrolimus (Primary)
- Indications Liver transplant rejection
- Focus Pharmacokinetics; Therapeutic Use
- Acronyms COBALT
- Sponsors Astellas Pharma
- 31 Aug 2017 Status changed from active, no longer recruiting to completed.
- 18 Jun 2017 Planned End Date changed from 1 Mar 2017 to 1 Jun 2017.
- 18 Jun 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Jun 2017.